3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myeloid, Acute
197
Leukemia
110
Lymphoma
90
Precursor Cell Lymphoblastic Leukemia-Lymphoma
86
Burkitt Lymphoma
52
Myelodysplastic Syndromes
47
Lymphoma, Mantle-Cell
47
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, Non-Hodgkin
46
Leukemia, Myelomonocytic, Acute
30
Lymphoma, Follicular
29
Leukemia, Monocytic, Acute
29
Recurrence
25
Congenital Abnormalities
25
Leukemia, Erythroblastic, Acute
24
Lymphoma, Large-Cell, Immunoblastic
23
Leukemia, Megakaryoblastic, Acute
23
Blast Crisis
21
Hodgkin Disease
20
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia, Myelomonocytic, Chronic
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Lymphoma, B-Cell, Marginal Zone
15
Anemia, Refractory, with Excess of Blasts
15
Leukemia, Myeloid, Accelerated Phase
13
Leukemia, Biphenotypic, Acute
13
Leukemia, Myeloid, Chronic-Phase
12
Dendritic Cell Sarcoma, Interdigitating
12
Myeloproliferative Disorders
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Interventions
Bevacizumab
10
Magnetic Resonance Spectroscopy
9
Temozolomide
8
Cyclophosphamide
8
Etoposide
7
X-Rays
6
Phantoms, Imaging
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Cisplatin
5
Radiotherapy
4
Irinotecan
4
Filgrastim
4
Carboplatin
4
Biopsy
4
Erlotinib Hydrochloride
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
sargramostim
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
Vincristine
2
Vemurafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Ependymoma
×
Cytarabine
×
Clear all
NCT01356290
2026-02-23
MEMMAT
Medical University of Vienna
Phase 2
Recruiting
232 enrolled